Đang chuẩn bị liên kết để tải về tài liệu:
Dynamic contrast-enhanced MRI in malignant pleural mesothelioma: Prediction of outcome based on DCE-MRI measurements in patients undergoing cytotoxic chemotherapy
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The malignant pleural mesothelioma (MPM) response rate to chemotherapy is low. The identification of imaging biomarkers that could help guide the most effective therapy approach for individual patients is highly desirable. |